Challenges of thyroid cancer management in amiodarone-treated patients: a case report

Thyroid carcinoma (TC) is the most common endocrine malignancy. Although the overall prognosis for patients with TC is good, up to 20–30% of patients have recurrent or persistent disease after conventional therapy by surgical resection and radioactive iodine (RAI). Amiodarone is a highly efficient a...

Descripción completa

Detalles Bibliográficos
Autores principales: PETRULEA, MIRELA SANDA, LENCU, CODRUTA, PICIU, DOINA, LISENCU, COSMIN IOAN, GEORGESCU, CARMEN EMANUELA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689250/
https://www.ncbi.nlm.nih.gov/pubmed/26733755
http://dx.doi.org/10.15386/cjmed-502
_version_ 1782406815261130752
author PETRULEA, MIRELA SANDA
LENCU, CODRUTA
PICIU, DOINA
LISENCU, COSMIN IOAN
GEORGESCU, CARMEN EMANUELA
author_facet PETRULEA, MIRELA SANDA
LENCU, CODRUTA
PICIU, DOINA
LISENCU, COSMIN IOAN
GEORGESCU, CARMEN EMANUELA
author_sort PETRULEA, MIRELA SANDA
collection PubMed
description Thyroid carcinoma (TC) is the most common endocrine malignancy. Although the overall prognosis for patients with TC is good, up to 20–30% of patients have recurrent or persistent disease after conventional therapy by surgical resection and radioactive iodine (RAI). Amiodarone is a highly efficient anti-arrhythmic drug with a very long half-life, so it may interfere with RAI many months after the drug withdrawal. This case report mirrors the challenges of thyroid cancer management in an amiodarone-treated patient.
format Online
Article
Text
id pubmed-4689250
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-46892502016-01-05 Challenges of thyroid cancer management in amiodarone-treated patients: a case report PETRULEA, MIRELA SANDA LENCU, CODRUTA PICIU, DOINA LISENCU, COSMIN IOAN GEORGESCU, CARMEN EMANUELA Clujul Med Case Reports Thyroid carcinoma (TC) is the most common endocrine malignancy. Although the overall prognosis for patients with TC is good, up to 20–30% of patients have recurrent or persistent disease after conventional therapy by surgical resection and radioactive iodine (RAI). Amiodarone is a highly efficient anti-arrhythmic drug with a very long half-life, so it may interfere with RAI many months after the drug withdrawal. This case report mirrors the challenges of thyroid cancer management in an amiodarone-treated patient. Iuliu Hatieganu University of Medicine and Pharmacy 2015 2015-11-15 /pmc/articles/PMC4689250/ /pubmed/26733755 http://dx.doi.org/10.15386/cjmed-502 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Case Reports
PETRULEA, MIRELA SANDA
LENCU, CODRUTA
PICIU, DOINA
LISENCU, COSMIN IOAN
GEORGESCU, CARMEN EMANUELA
Challenges of thyroid cancer management in amiodarone-treated patients: a case report
title Challenges of thyroid cancer management in amiodarone-treated patients: a case report
title_full Challenges of thyroid cancer management in amiodarone-treated patients: a case report
title_fullStr Challenges of thyroid cancer management in amiodarone-treated patients: a case report
title_full_unstemmed Challenges of thyroid cancer management in amiodarone-treated patients: a case report
title_short Challenges of thyroid cancer management in amiodarone-treated patients: a case report
title_sort challenges of thyroid cancer management in amiodarone-treated patients: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689250/
https://www.ncbi.nlm.nih.gov/pubmed/26733755
http://dx.doi.org/10.15386/cjmed-502
work_keys_str_mv AT petruleamirelasanda challengesofthyroidcancermanagementinamiodaronetreatedpatientsacasereport
AT lencucodruta challengesofthyroidcancermanagementinamiodaronetreatedpatientsacasereport
AT piciudoina challengesofthyroidcancermanagementinamiodaronetreatedpatientsacasereport
AT lisencucosminioan challengesofthyroidcancermanagementinamiodaronetreatedpatientsacasereport
AT georgescucarmenemanuela challengesofthyroidcancermanagementinamiodaronetreatedpatientsacasereport

Ejemplares similares